Ondansetron
- Product NDC
- 0409-2271
- 11-digit product format
- 004092271
- Labeler code
- 0409
- Product ID
- 0409-2271_e0862c02-781f-4b10-ae50-9c9c4ca26f6d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ONDANSETRON
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Hospira, Inc.
- Application
- ANDA077548
- Marketing category
- ANDA
- Marketing start
- 2025-12-01
- Substance
- ONDANSETRON HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ondansetron
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ONDANSETRON HYDROCHLORIDE | 2 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | NMH84OZK2B |
| Rxcui | 1740467 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0409-2271-02 | Ondansetron | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | | 1 |
| 0409-2271-25 | Ondansetron | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 0409-2271-02 | 00409227102 | 2 mL in 1 VIAL, SINGLE-DOSE | 2 ml | | | | Historical |
| 0409-2271-25 | 00409227125 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-2271-25) / 2 mL in 1 VIAL, SINGLE-DOSE (0409-2271-02) | | 2025-12-01 | No | No | Current |